The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

Iraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.

International Journal of Women's Health and Reproduction Sciences, published by ARAS PART MEDICAL INT PRESS, stands as a pivotal platform for the dissemination of research and scholarly work in the fields of obstetrics, gynecology, and reproductive health. Established in 2013, this journal aims to advance the understanding of women's health issues and reproductive sciences, fostering a multidisciplinary approach that encourages collaboration amongst healthcare professionals, researchers, and students. With an ISSN of 2330-4456, it operates under a rigorous editorial process that ensures the publication of high-quality research. The journal has been recognized in 2023 with a Q3 ranking in Obstetrics and Gynecology and a Q4 ranking in Reproductive Medicine, indicating its growing influence and the importance of its contributions to the field. Currently, it ranks #128 out of 209 in Obstetrics and Gynecology and #62 out of 90 in Reproductive Medicine on Scopus, positioning it within the global academic discourse. Although it operates without an open access model, its contributions are critical for those dedicated to advancing medical knowledge and practices regarding women's health. For researchers and professionals committed to improving reproductive health care and enhancing women's health outcomes, this journal serves as an essential resource.

The Journal of Cancer Survivorship, published by SPRINGER, serves as a premier platform for research dedicated to the complex realities faced by cancer survivors. Established in 2007, this esteemed journal focuses on the multifaceted aspects of oncology care, particularly within the nursing domain, reflecting its significance with a 2023 Q1 ranking in both Oncology and Oncology (nursing) categories. Additionally, it boasts impressive Scopus rankings, positioning it in the top tier of nursing and oncology fields. Targeted towards researchers, healthcare professionals, and students, the journal emphasizes advancements in survivorship care, psychosocial support, and health-related quality of life post-cancer treatment. With no open access option, the journal maintains a high standard of scholarly communications while ensuring rigorous peer review processes, making it an indispensable resource in the evolving landscape of cancer survivorship studies.

Dermatologie, published by SPRINGER HEIDELBERG, is a prominent journal dedicated to the advancing field of dermatology. With its ISSN 2731-7005 and E-ISSN 2731-7013, this journal has established itself as a valuable resource for researchers, professionals, and students alike. Originating in Germany, the journal focuses on disseminating innovative research from 2022 to 2024, contributing significantly to the understanding of skin health and disease management. Despite its current ranking within the Q3 category in dermatology and a Scopus rank of #88/142, it provides critical insights and advances in clinical practice, epidemiology, and therapeutic modalities. With an emphasis on open discourse, it seeks to foster collaboration among healthcare professionals and researchers, thereby enhancing the quality and accessibility of dermatological research. Engage with Dermatologie to stay at the forefront of the latest advancements in skin-related health issues.

JAMA Oncology, published by the American Medical Association, stands at the forefront of cancer research as a premier peer-reviewed journal in the field. With an ISSN of 2374-2437 and an impressive impact factor reflecting its critical insights, the journal has achieved a top-tier position, being ranked in the Q1 quartile for both Cancer Research and Oncology as of 2023, and demonstrating exceptional performance in Medicine as well. Spanning a converged publication period from 2015 through 2024, JAMA Oncology publishes cutting-edge research, clinical trials, and reviews that are pivotal in advancing our understanding and treatment of cancer. The journal's Scopus ranks highlight its global impact, placing it in the top deciles within its categories, ensuring that it remains a vital resource for oncologists, researchers, and students alike. While it currently does not offer open access, JAMA Oncology continues to provide invaluable contributions to the scientific community, promoting a deeper understanding of oncological challenges and breakthroughs.

Chronic Obstructive Pulmonary Diseases - Journal of the COPD Foundation, published by the esteemed COPD Foundation, serves as a vital platform for advancing research in the field of pulmonary and respiratory medicine. With an ISSN of 2372-952X, this journal emphasizes the exploration and dissemination of knowledge related to chronic obstructive pulmonary disease (COPD) while addressing broader topics in respiratory health. Recognized within the Q2 category of the 2023 *Scopus* rankings and positioned at the 47th percentile in its field, the journal showcases innovative studies, clinical insights, and evidence-based practices crucial for professionals, researchers, and students alike. Although operating as a traditional publication, it seeks to provide immediate access to groundbreaking research on the prevention and management of COPD, facilitating improved patient outcomes. As it continues to expand its influence since its convergence in 2018, this journal is dedicated to bridging gaps in pulmonary medicine, making it an indispensable resource for the global respiratory health community.

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

American Journal of Physical Medicine & Rehabilitation, published by Lippincott Williams & Wilkins, is a leading journal in the field of rehabilitation, dedicated to advancing knowledge in physical medicine and rehabilitation practices. With an established history from 1988 to 2024, this journal serves as a vital resource for clinicians, researchers, and students interested in the multifaceted aspects of rehabilitation science. It holds a commendable Q2 ranking in the Physical Therapy and Sports Therapy fields and a prestigious Q1 position in Rehabilitation, reflecting its impact and relevance in the academic community. The journal's Scopus rankings further highlight its significance, placing it among the top percentile for both rehabilitation medicine and physical therapy. Although it does not currently offer open access options, its accessibility through institutional subscriptions ensures widespread reach. By publishing high-quality research, clinical studies, and reviews, the American Journal of Physical Medicine & Rehabilitation plays a critical role in shaping contemporary rehabilitation practices and improving patient outcomes.

Basic and Clinical Andrology, published by BMC, is a leading open access journal dedicated to the advancement of knowledge in the field of reproductive medicine and urology. Since its launch in 2013, the journal has aimed to provide a platform for the dissemination of high-quality research, bridging the gap between basic science and clinical practice. With an impressive reputation evidenced by its Q2 ranking in both reproductive medicine and urology, it serves as a vital resource for researchers, healthcare professionals, and students looking to stay updated on the latest developments in andrology. The journal actively encourages submissions across a diverse range of topics, contributing to our understanding of male reproductive health issues, advancements in treatment protocols, and innovative therapeutic approaches. Located in the United Kingdom, Basic and Clinical Andrology plays a critical role in the global discourse on andrology, offering researchers an opportunity to share their findings with a broad audience committed to improving health outcomes in these crucial fields.